|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0025260,
umls-concept:C0032659,
umls-concept:C0039194,
umls-concept:C0085358,
umls-concept:C0205100,
umls-concept:C0547047,
umls-concept:C0887947,
umls-concept:C1155065,
umls-concept:C1274040,
umls-concept:C1332714,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1706438,
umls-concept:C2698600
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-2-26
|
|
pubmed:abstractText |
Highly active antiretroviral therapy (HAART) can produce marked increases in peripheral blood CD4+ T cells and decreases in HIV plasma RNA copy numbers. However, it is not clear whether these absolute changes will be accompanied by a recovery in the known naive CD4+ T cell depletion or a decrease in the marked CD8+ T cell activation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0166-3542
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
163-73
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9833957-Anti-HIV Agents,
pubmed-meshheading:9833957-Antigens, CD,
pubmed-meshheading:9833957-CD4 Lymphocyte Count,
pubmed-meshheading:9833957-CD4-Positive T-Lymphocytes,
pubmed-meshheading:9833957-CD8-Positive T-Lymphocytes,
pubmed-meshheading:9833957-Drug Therapy, Combination,
pubmed-meshheading:9833957-Flow Cytometry,
pubmed-meshheading:9833957-HIV Infections,
pubmed-meshheading:9833957-HIV Protease Inhibitors,
pubmed-meshheading:9833957-HIV-1,
pubmed-meshheading:9833957-Humans,
pubmed-meshheading:9833957-Immunologic Memory,
pubmed-meshheading:9833957-Immunophenotyping,
pubmed-meshheading:9833957-Indinavir,
pubmed-meshheading:9833957-Lamivudine,
pubmed-meshheading:9833957-Lymphocyte Activation,
pubmed-meshheading:9833957-Statistics, Nonparametric,
pubmed-meshheading:9833957-T-Lymphocyte Subsets,
pubmed-meshheading:9833957-Viral Load,
pubmed-meshheading:9833957-Zidovudine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
|
|
pubmed:affiliation |
Infectious Diseases Unit, University of Rochester, NY, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Controlled Clinical Trial
|
